TRC210258 is a TGR5 agonist. It acts by reducing glycemic and dyslipidemic cardiovascular risk in animal models of diabesity. References: Zambad SP, Tuli D, Mathur A, Ghalsasi SA, Chaudhary AR, Deshpande S, Gupta RC, Chauthaiwale V, Dutt C. TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity. Diabetes Metab Syndr Obes. 2013 Dec 21;7:1-14. doi: 10.2147/DMSO.S50209. eCollection 2013. PubMed PMID: 24379686; PubMed Central PMCID: PMC3873233.

纯度：≥98%

CAS：1431553-15-9